# FDA Inspection 898018 - Breckenridge Pharmaceutical, Inc - September 25, 2014

Source: https://www.keypedia.com/records/fda_inspections/breckenridge-pharmaceutical-inc/b816742d-a388-4f3a-b80b-6433f1da97dd
Source feed: FDA_Inspections

> FDA Inspection 898018 for Breckenridge Pharmaceutical, Inc on September 25, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 898018
- Company Name: Breckenridge Pharmaceutical, Inc
- Inspection Date: 2014-09-25
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1227134 - 2024-01-05](https://www.keypedia.com/records/fda_inspections/breckenridge-pharmaceutical-inc/bced68b6-0d9c-4e72-9b7c-791d22d43ff7)
- [FDA Inspection 1082461 - 2019-01-29](https://www.keypedia.com/records/fda_inspections/breckenridge-pharmaceutical-inc/a637da50-df96-4b87-9424-c12d8a91c760)
- [FDA Inspection 1003361 - 2017-02-21](https://www.keypedia.com/records/fda_inspections/breckenridge-pharmaceutical-inc/72d47b07-fce9-4a7c-b96f-de03f8f6c396)
- [FDA Inspection 1003361 - 2017-02-21](https://www.keypedia.com/records/fda_inspections/breckenridge-pharmaceutical-inc/09629747-3611-4bd0-90fb-2619e164b143)
- [FDA Inspection 727340 - 2011-05-17](https://www.keypedia.com/records/fda_inspections/breckenridge-pharmaceutical-inc/62064836-b088-4551-83b0-350ad1f8a049)

Company: https://www.keypedia.com/companies/breckenridge-pharmaceutical-inc/0dd54385-a0e5-4eb8-92f1-eeb2f161933e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c